Skip to main content

Advertisement

SpringerLink
Log in

Evidence for regional hippocampal damage in patients with schizophrenia

  • Functional Neuroradiology
  • Published:
Neuroradiology Aims and scope Submit manuscript

Abstract

Purpose

Schizophrenia patients show cognitive and mood impairments, including memory loss and depression, suggesting damage in the brain regions. The hippocampus is a brain structure that is significantly involved in memory and mood function and shows impairment in schizophrenia. In the present study, we examined the regional hippocampal changes in schizophrenia patients using voxel-based morphometry (VBM), Freesurfer, and proton magnetic resonance spectroscopy (1H MRS) procedures.

Methods

1H MRS and high-resolution T1-weighted magnetic resonance imaging were collected in both healthy control subjects (N = 28) and schizophrenia patients (N = 28) using 3-Tesla whole body MRI system. Regional hippocampal volume was analyzed using VBM and Freesufer procedures. The relative ratios of the neurometabolites were calculated using linear combination model (LCModel).

Results

Compared to controls, schizophrenia patients showed significantly decreased gray matter volume in the hippocampus. Schizophrenia patients also showed significantly reduced glutamate (Glu) and myo-inositol (mI) ratios in the hippocampus. Additionally, significant positive correlation between gray matter volume and Glu/tCr was also observed in the hippocampus in schizophrenia.

Conclusion

Our findings provide an evidence for a possible association between structural deficits and metabolic alterations in schizophrenia patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Mueller S, Keeser D, Reiser MF, Teipel S, Meindl T (2012) Functional and structural MR imaging in neuropsychiatric disorders, part 2: application in schizophrenia and autism. AJNR Am J Neuroradiol 33(11):2033–2037. https://doi.org/10.3174/ajnr.A2800

    Article  CAS  PubMed  Google Scholar 

  2. Penn DL, Spaulding W, Reed D, Sullivan M, Mueser KT, Hope DA (1997) Cognition and social functioning in schizophrenia. Psychiatry 60(4):281–291. https://doi.org/10.1080/00332747.1997.11024806

    Article  CAS  PubMed  Google Scholar 

  3. Goldberg TEGM (2002) Neurocognitive functioning in patients with schizophrenia: an overview. In: Davis KLCD, Coyle JT, Nemeroff C (eds) Neuropsychopharmacology—fifth generation of progress, pp 657–669

    Google Scholar 

  4. Mulholland CCS (2000) The symptom of depression in schizophrenia and its management. Adv Psychiatr Treat 6(3):169–177. https://doi.org/10.1192/apt.6.3.169

    Article  Google Scholar 

  5. Harvey PD (2011) Mood symptoms, cognition, and everyday functioning: in major depression, bipolar disorder, and schizophrenia. Innov Clin Neurosci 8(10):14–18

    PubMed  PubMed Central  Google Scholar 

  6. Harrison PJ (2004) The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications. Psychopharmacology 174(1):151–162. https://doi.org/10.1007/s00213-003-1761-y

    Article  CAS  PubMed  Google Scholar 

  7. Heckers S (2001) Neuroimaging studies of the hippocampus in schizophrenia. Hippocampus 11(5):520–528. https://doi.org/10.1002/hipo.1068

    Article  CAS  PubMed  Google Scholar 

  8. Wible CG (2013) Hippocampal physiology, structure and function and the neuroscience of schizophrenia: a unified account of declarative memory deficits, working memory deficits and schizophrenic symptoms. Behav Sci (Basel) 3(2):298–315. https://doi.org/10.3390/bs3020298

    Article  Google Scholar 

  9. Tamminga CA, Stan AD, Wagner AD (2010) The hippocampal formation in schizophrenia. Am J Psychiatry 167(10):1178–1193. https://doi.org/10.1176/appi.ajp.2010.09081187

    Article  PubMed  Google Scholar 

  10. Shepherd AM, Laurens KR, Matheson SL, Carr VJ, Green MJ (2012) Systematic meta-review and quality assessment of the structural brain alterations in schizophrenia. Neurosci Biobehav Rev 36(4):1342–1356. https://doi.org/10.1016/j.neubiorev.2011.12.015

    Article  PubMed  Google Scholar 

  11. Glahn DC, Laird AR, Ellison-Wright I, Thelen SM, Robinson JL, Lancaster JL, Bullmore E, Fox PT (2008) Meta-analysis of gray matter anomalies in schizophrenia: application of anatomic likelihood estimation and network analysis. Biol Psychiatry 64(9):774–781. https://doi.org/10.1016/j.biopsych.2008.03.031

    Article  PubMed  PubMed Central  Google Scholar 

  12. Asami T, Bouix S, Whitford TJ, Shenton ME, Salisbury DF, McCarley RW (2012) Longitudinal loss of gray matter volume in patients with first-episode schizophrenia: DARTEL automated analysis and ROI validation. NeuroImage 59(2):986–996. https://doi.org/10.1016/j.neuroimage.2011.08.066

    Article  PubMed  Google Scholar 

  13. Williams LM (2008) Voxel-based morphometry in schizophrenia: implications for neurodevelopmental connectivity models, cognition and affect. Expert Rev Neurother 8(7):1049–1065. https://doi.org/10.1586/14737175.8.7.1049

    Article  PubMed  Google Scholar 

  14. Steen RG, Hamer RM, Lieberman JA (2005) Measurement of brain metabolites by 1H magnetic resonance spectroscopy in patients with schizophrenia: a systematic review and meta-analysis. Neuropsychopharmacology 30(11):1949–1962. https://doi.org/10.1038/sj.npp.1300850

    Article  CAS  PubMed  Google Scholar 

  15. Deicken RF, Zhou L, Schuff N, Fein G, Weiner MW (1998) Hippocampal neuronal dysfunction in schizophrenia as measured by proton magnetic resonance spectroscopy. Biol Psychiat 43(7):483–488. https://doi.org/10.1016/S0006-3223(97)00490-3

    Article  CAS  PubMed  Google Scholar 

  16. van Elst LT, Valerius G, Buchert M, Thiel T, Rusch N, Bubl E, Hennig J, Ebert D, Olbrich HM (2005) Increased prefrontal and hippocampal glutamate concentration in schizophrenia: evidence from a magnetic resonance spectroscopy study. Biol Psychiatry 58(9):724–730. https://doi.org/10.1016/j.biopsych.2005.04.041

    Article  PubMed  Google Scholar 

  17. Rusch N, van Elst LT, Valerius G, Buchert M, Thiel T, Ebert D, Hennig J, Olbrich HM (2008) Neurochemical and structural correlates of executive dysfunction in schizophrenia. Schizophr Res 99(1–3):155–163. https://doi.org/10.1016/j.schres.2007.05.024

    Article  PubMed  Google Scholar 

  18. Hutcheson NL, Reid MA, White DM, Kraguljac NV, Avsar KB, Bolding MS, Knowlton RC, den Hollander JA, Lahti AC (2012) Multimodal analysis of the hippocampus in schizophrenia using proton magnetic resonance spectroscopy and functional magnetic resonance imaging. Schizophr Res 140(1–3):136–142. https://doi.org/10.1016/j.schres.2012.06.039

    Article  PubMed  PubMed Central  Google Scholar 

  19. Kraguljac NV, White DM, Reid MA, Lahti AC (2013) Increased hippocampal glutamate and volumetric deficits in unmedicated patients with schizophrenia. Jama Psychiat 70(12):1294–1302. https://doi.org/10.1001/jamapsychiatry.2013.2437

    Article  CAS  Google Scholar 

  20. Hasan A, Wobrock T, Falkai P, Schneider-Axmann T, Guse B, Backens M, Ecker UKH, Heimes J, Galea JM, Gruber O, Scherk H (2014) Hippocampal integrity and neurocognition in first-episode schizophrenia: a multidimensional study. World J Biol Psychia 15(3):188–199. https://doi.org/10.3109/15622975.2011.620002

    Article  Google Scholar 

  21. Nurnberger JI, Blehar MC, Kaufmann CA, Yorkcooler C, Simpson SG, Harkavyfriedman J, Severe JB, Malaspina D, Reich T, Miller M, Bowman ES, Depaulo JR, Cloninger CR, Robinson G, Modlin S, Gershon ES, Maxwell E, Guroff JJ, Kirch D, Wynne D, Berg K, Tsuang MT, Faraone SV, Pepple JR, Ritz AL (1994) Diagnostic interview for genetic studies—rationale, unique features, and training. Arch Gen Psychiat 51(11):849–859. https://doi.org/10.1001/archpsyc.1994.03950110009002

    Article  PubMed  Google Scholar 

  22. Deshpande SN, Mathur MNL, Das SK, Bhatia T, Sharma S, Nimgaonkar VL (1998) A Hindi version of the diagnostic interview for genetic studies. Schizophrenia Bull 24(3):489–493. https://doi.org/10.1093/oxfordjournals.schbul.a033343

    Article  CAS  Google Scholar 

  23. Ashburner J (2010) VBM Tutorial

  24. Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C, van der Kouwe A, Killiany R, Kennedy D, Klaveness S, Montillo A, Makris N, Rosen B, Dale AM (2002) Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 33(3):341–355. https://doi.org/10.1016/S0896-6273(02)00569-X

    Article  CAS  PubMed  Google Scholar 

  25. Provencher SW (1993) Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magnet Reson Med 30(6):672–679. https://doi.org/10.1002/mrm.1910300604

    Article  CAS  Google Scholar 

  26. Provencher SW (2001) Automatic quantitation of localized in vivo 1H spectra with LCModel. NMR Biomed 14(4):260–264. https://doi.org/10.1002/nbm.698

    Article  CAS  PubMed  Google Scholar 

  27. Cavassila S, Deval S, Huegen C, van Ormondt D, Graveron-Demilly D (2001) Cramer-Rao bounds: an evaluation tool for quantitation. NMR Biomed 14(4):278–283. https://doi.org/10.1002/nbm.701

    Article  CAS  PubMed  Google Scholar 

  28. da Silva Alves F, Boot E, Schmitz N, Nederveen A, Vorstman J, Lavini C, Pouwels PJ, de Haan L, Linszen D, van Amelsvoort T (2011) Proton magnetic resonance spectroscopy in 22q11 deletion syndrome. PLoS One 6(6):e21685. https://doi.org/10.1371/journal.pone.0021685

    Article  PubMed  PubMed Central  Google Scholar 

  29. Chang L, Friedman J, Ernst T, Zhong K, Tsopelas ND, Davis K (2007) Brain metabolite abnormalities in the white matter of elderly schizophrenic subjects: implication for glial dysfunction. Biol Psychiatry 62(12):1396–1404. https://doi.org/10.1016/j.biopsych.2007.05.025

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Kegeles LS, Mao X, Stanford AD, Girgis R, Ojeil N, Xu X, Gil R, Slifstein M, Abi-Dargham A, Lisanby SH, Shungu DC (2012) Elevated prefrontal cortex gamma-aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy. Arch Gen Psychiatry 69(5):449–459. https://doi.org/10.1001/archgenpsychiatry.2011.1519

    Article  CAS  PubMed  Google Scholar 

  31. de la Fuente-Sandoval C, Leon-Ortiz P, Azcarraga M, Favila R, Stephano S, Graff-Guerrero A (2013) Striatal glutamate and the conversion to psychosis: a prospective 1H-MRS imaging study. Int J Neuropsychopharmacol 16(2):471–475. https://doi.org/10.1017/S1461145712000314

    Article  PubMed  Google Scholar 

  32. Olbrich HM, Valerius G, Rusch N, Buchert M, Thiel T, Hennig J, Ebert D, Van Elst LT (2008) Frontolimbic glutamate alterations in first episode schizophrenia: evidence from a magnetic resonance spectroscopy study. World J Biol Psychiatry 9(1):59–63. https://doi.org/10.1080/15622970701227811

    Article  PubMed  Google Scholar 

  33. Nenadic I, Maitra R, Basu S, Dietzek M, Schonfeld N, Lorenz C, Gussew A, Amminger GP, McGorry P, Reichenbach JR, Sauer H, Gaser C, Smesny S (2015) Associations of hippocampal metabolism and regional brain grey matter in neuroleptic-naive ultra-high-risk subjects and first-episode schizophrenia. Eur Neuropsychopharmacol 25(10):1661–1668. https://doi.org/10.1016/j.euroneuro.2015.05.005

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. NMR Research Centre, Institute of Nuclear Medicine and Allied Sciences (INMAS), DRDO, Lucknow Road, Timarpur, Delhi, India

    Sadhana Singh, Subash Khushu & Pawan Kumar

  2. Post Graduate Institute of Medical Education and Research (PGIMER), RML Hospital, New Delhi, India

    Satnam Goyal, Triptish Bhatia & Smita N Deshpande

Authors
  1. Sadhana Singh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Subash Khushu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Pawan Kumar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Satnam Goyal
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Triptish Bhatia
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Smita N Deshpande
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Subash Khushu.

Ethics declarations

Funding

This study was funded by DRDO R&D Project No. INM-311(4.1) and funded in part by grant from the Fogarty International Centre, NIH, The Impact of Yoga Supplementation on Cognitive Function Among Indian Outpatients Grant #1R01TW008289 to TB.

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in the studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Singh, S., Khushu, S., Kumar, P. et al. Evidence for regional hippocampal damage in patients with schizophrenia. Neuroradiology 60, 199–205 (2018). https://doi.org/10.1007/s00234-017-1954-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00234-017-1954-4

Keywords

Search

Navigation